Journal of Medicinal Chemistry· 2026Q1
Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers
- 1citations
- Q1SCImago
- 2026year
Short summary
DT-9081, a novel small molecule EP4 receptor antagonist, shows potent antagonism and favorable preclinical safety, making it a promising oral treatment candidate for solid cancers.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pharmacology
PharmacologyMedicine